TREAT ctDNA Elacestrant

Conditions:   ER-positive Breast Cancer;   HER2-negative Breast Cancer;   Stage IIB Breast Cancer;   Stage III Breast Cancer Interventions:   Drug: Elacestrant;   Drug: Tamoxifen;   Drug: Letrozole 2.5mg;   Drug: Anastrozole 1mg;   Drug: Exemestane 25 MG Sponsors:   European Organisation for Research and Treatment of Cancer - EORTC;   Breast International Group;   Menarini Group Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials